Chronic Heart Failure: LCZ-696 and ivabradine | Current Treatment | US | 2016

Chronic heart failure patients are subject to high rates of mortality and morbidity and frequent readmissions to the hospital mean that chronic heart failure also represents a significant healthcare burden. The Current Treatment Chronic Heart Failure (US) report offers a snapshot of how U.S. cardiologists prescribe currently available therapies, provides insight into the factors driving such prescribing habits, as well as anticipated future changes in prescribing practices.

Login to access report

launch Related Market Assessment Reports